Literature DB >> 10841542

Analysis of mutations and suppressors affecting interactions between the subunits of the HIV type 1 reverse transcriptase.

G Tachedjian1, H E Aronson, S P Goff.   

Abstract

HIV-1 reverse transcriptase (RT) catalyzes the conversion of genomic RNA into cDNA. The enzyme is a heterodimer of p66 and p51 subunits, and the dimerization of these subunits is required for optimal enzyme activity. To analyze this process at the genetic level, we developed constructs that permit the detection of the interaction between these subunits in the yeast two-hybrid system. Genetic analysis of RT subdomains required for heterodimerization revealed that the fingers and palm of p66 were dispensable for p51 interaction. However, as little as a 26-amino acid deletion at the C terminus of p51 prevented dimerization with p66. A primer grip mutation, L234A, previously shown to inhibit RT dimerization by biochemical assays, also prevented RT dimerization in the yeast two-hybrid system. Second-site mutations that restored RT dimerization in yeast to the L234A parent were recovered in the tryptophan repeat region at the dimer interface and at the polymerase active site, suggesting the involvement of these sites in RT dimerization. In vitro binding experiments confirmed the effects of the L234A mutation and the suppressor mutations on the interaction of the two subunits. The RT two-hybrid assay should facilitate the extensive genetic analysis of RT dimerization and should make possible the rapid screening of potential inhibitors of this essential process.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10841542      PMCID: PMC18603          DOI: 10.1073/pnas.97.12.6334

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  Mixed reconstitution of mutated subunits of HIV-1 reverse transcriptase coexpressed in Escherichia coli - two tags tie it up.

Authors:  G Maier; U Dietrich; B Panhans; B Schröder; H Rübsamen-Waigmann; L Cellai; T Hermann; H Heumann
Journal:  Eur J Biochem       Date:  1999-04

2.  High resolution structures of HIV-1 RT from four RT-inhibitor complexes.

Authors:  J Ren; R Esnouf; E Garman; D Somers; C Ross; I Kirby; J Keeling; G Darby; Y Jones; D Stuart
Journal:  Nat Struct Biol       Date:  1995-04

3.  Protein-protein interactions of HIV-1 reverse transcriptase: implication of central and C-terminal regions in subunit binding.

Authors:  S P Becerra; A Kumar; M S Lewis; S G Widen; J Abbotts; E M Karawya; S H Hughes; J Shiloach; S H Wilson; M S Lewis
Journal:  Biochemistry       Date:  1991-12-17       Impact factor: 3.162

4.  Complete nucleotide sequence of the AIDS virus, HTLV-III.

Authors:  L Ratner; W Haseltine; R Patarca; K J Livak; B Starcich; S F Josephs; E R Doran; J A Rafalski; E A Whitehorn; K Baumeister
Journal:  Nature       Date:  1985 Jan 24-30       Impact factor: 49.962

5.  DNA specificity of the bicoid activator protein is determined by homeodomain recognition helix residue 9.

Authors:  S D Hanes; R Brent
Journal:  Cell       Date:  1989-06-30       Impact factor: 41.582

6.  Alterations to the primer grip of p66 HIV-1 reverse transcriptase and their consequences for template-primer utilization.

Authors:  M Ghosh; P S Jacques; D W Rodgers; M Ottman; J L Darlix; S F Le Grice
Journal:  Biochemistry       Date:  1996-07-02       Impact factor: 3.162

7.  A novel genetic system to detect protein-protein interactions.

Authors:  S Fields; O Song
Journal:  Nature       Date:  1989-07-20       Impact factor: 49.962

8.  Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 A resolution shows bent DNA.

Authors:  A Jacobo-Molina; J Ding; R G Nanni; A D Clark; X Lu; C Tantillo; R L Williams; G Kamer; A L Ferris; P Clark
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

9.  Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance.

Authors:  H Huang; R Chopra; G L Verdine; S C Harrison
Journal:  Science       Date:  1998-11-27       Impact factor: 47.728

10.  Site-specific mutagenesis of AIDS virus reverse transcriptase.

Authors:  B A Larder; D J Purifoy; K L Powell; G Darby
Journal:  Nature       Date:  1987 Jun 25-Jul 1       Impact factor: 49.962

View more
  25 in total

Review 1.  Conformational changes in HIV-1 reverse transcriptase induced by nonnucleoside reverse transcriptase inhibitor binding.

Authors:  Nicolas Sluis-Cremer; N Alpay Temiz; Ivet Bahar
Journal:  Curr HIV Res       Date:  2004-10       Impact factor: 1.581

2.  Mutual information analysis reveals coevolving residues in Tat that compensate for two distinct functions in HIV-1 gene expression.

Authors:  Siddharth S Dey; Yuhua Xue; Marcin P Joachimiak; Gregory D Friedland; John C Burnett; Qiang Zhou; Adam P Arkin; David V Schaffer
Journal:  J Biol Chem       Date:  2012-01-17       Impact factor: 5.157

3.  Nonnucleoside reverse transcriptase inhibitor-resistant HIV is stimulated by efavirenz during early stages of infection.

Authors:  Jiong Wang; Gang Zhang; Robert A Bambara; Dongge Li; Hua Liang; Hulin Wu; Hannah M Smith; Nicholas R Lowe; Lisa M Demeter; Carrie Dykes
Journal:  J Virol       Date:  2011-08-10       Impact factor: 5.103

4.  Systematic study of the genetic response of a variable virus to the introduction of deleterious mutations in a functional capsid region.

Authors:  Eva Luna; Alicia Rodríguez-Huete; Verónica Rincón; Roberto Mateo; Mauricio G Mateu
Journal:  J Virol       Date:  2009-07-22       Impact factor: 5.103

5.  Nonnucleoside reverse transcriptase inhibitors are chemical enhancers of dimerization of the HIV type 1 reverse transcriptase.

Authors:  G Tachedjian; M Orlova; S G Sarafianos; E Arnold; S P Goff
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-19       Impact factor: 11.205

6.  Antiviral activity and in vitro mutation development pathways of MK-6186, a novel nonnucleoside reverse transcriptase inhibitor.

Authors:  Meiqing Lu; Peter J Felock; Vandna Munshi; Renee C Hrin; Ying-Jie Wang; Youwei Yan; Sanjeev Munshi; Georgia B McGaughey; Robert Gomez; Neville J Anthony; Theresa M Williams; Jay A Grobler; Daria J Hazuda; Philip M McKenna; Michael D Miller; Ming-Tain Lai
Journal:  Antimicrob Agents Chemother       Date:  2012-03-05       Impact factor: 5.191

7.  Homodimerization of the p51 subunit of HIV-1 reverse transcriptase.

Authors:  Xunhai Zheng; Geoffrey A Mueller; Matthew J Cuneo; Eugene F Derose; Robert E London
Journal:  Biochemistry       Date:  2010-04-06       Impact factor: 3.162

8.  Effect of tRNA on the Maturation of HIV-1 Reverse Transcriptase.

Authors:  Tatiana V Ilina; Ryan L Slack; John H Elder; Stefan G Sarafianos; Michael A Parniak; Rieko Ishima
Journal:  J Mol Biol       Date:  2018-05-08       Impact factor: 5.469

9.  A single amino acid substitution in HIV-1 reverse transcriptase significantly reduces virion release.

Authors:  Chien-Cheng Chiang; Shiu-Mei Wang; Yen-Yu Pan; Kuo-Jung Huang; Chin-Tien Wang
Journal:  J Virol       Date:  2009-11-04       Impact factor: 5.103

10.  Characterization of novel non-nucleoside reverse transcriptase (RT) inhibitor resistance mutations at residues 132 and 135 in the 51 kDa subunit of HIV-1 RT.

Authors:  Dwight V Nissley; Jessica Radzio; Zandrea Ambrose; Chih-Wei Sheen; Noureddine Hamamouch; Katie L Moore; Gilda Tachedjian; Nicolas Sluis-Cremer
Journal:  Biochem J       Date:  2007-05-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.